Loading...
Cellebrite DI Ltd.
CLBT•NASDAQ
Technology
Software - Infrastructure
$14.32
$-0.26(-1.78%)
Cellebrite DI Ltd. (CLBT) Financial Performance & Income Statement Overview
Review Cellebrite DI Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
23.41%
↑ 23.41%
Operating Income Growth
71.21%
↑ 71.21%
Net Income Growth
-248.96%
↓ 248.96%
Operating Cash Flow Growth
29.51%
↑ 29.51%
Operating Margin
14.30%
↑ 14.30%
Gross Margin
84.06%
↑ 84.06%
Net Profit Margin
-46.34%
↓ 46.34%
ROE
-81.13%
↓ 81.13%
ROIC
14.20%
↑ 14.20%
Cellebrite DI Ltd. (CLBT) Income Statement & Financial Overview
Review Cellebrite DI Ltd.'s (CLBT) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $109.05M | $106.86M | $95.71M | $89.58M |
Cost of Revenue | $17.62M | $15.44M | $16.26M | $13.26M |
Gross Profit | $91.42M | $91.41M | $79.45M | $76.32M |
Gross Profit Ratio | $0.84 | $0.86 | $0.83 | $0.85 |
R&D Expenses | $25.60M | $25.93M | $23.69M | $23.20M |
SG&A Expenses | $50.10M | $46.04M | $43.27M | $43.87M |
Operating Expenses | $75.70M | $71.97M | $66.97M | $67.06M |
Total Costs & Expenses | $93.32M | $87.41M | $83.23M | $80.33M |
Interest Income | $4.17M | $0.00 | $922000.00 | $0.00 |
Interest Expense | -$1.35M | $223.98M | $34.50M | $78.58M |
Depreciation & Amortization | $2.73M | $2.62M | $2.58M | $2.68M |
EBITDA | $18.46M | $22.07M | $15.06M | $11.93M |
EBITDA Ratio | $0.17 | $0.21 | $0.16 | $0.13 |
Operating Income | $15.73M | $19.45M | $12.49M | $9.26M |
Operating Income Ratio | $0.14 | $0.18 | $0.13 | $0.10 |
Other Income/Expenses (Net) | $4.17M | -$223.98M | -$34.50M | -$78.58M |
Income Before Tax | $19.90M | -$204.54M | -$22.02M | -$69.33M |
Income Before Tax Ratio | $0.18 | -$1.91 | -$0.23 | -$0.77 |
Income Tax Expense | $628000.00 | $2.56M | $1.80M | $2.04M |
Net Income | $19.27M | -$207.09M | -$23.81M | -$71.37M |
Net Income Ratio | $0.18 | -$1.94 | -$0.25 | -$0.80 |
EPS | $0.08 | -$0.99 | -$0.12 | -$0.36 |
Diluted EPS | $0.08 | -$0.99 | -$0.12 | -$0.36 |
Weighted Avg Shares Outstanding | $233.25M | $208.71M | $198.95M | $196.82M |
Weighted Avg Shares Outstanding (Diluted) | $247.35M | $208.71M | $198.95M | $196.82M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan